The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 171.20
Bid: 171.20
Ask: 172.20
Change: 3.40 (2.03%)
Spread: 1.00 (0.584%)
Open: 166.80
High: 172.40
Low: 166.80
Prev. Close: 167.80
CCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

19 Mar 2024 07:00

RNS Number : 3139H
C&C Group Plc
19 March 2024
 

C&C GROUP PLC

TRANSACTION IN OWN SHARES

C&C Group plc ("C&C" or the "Company") announces that on Monday, March 18, 2024 it purchased the following number of its ordinary shares of ?0.01 each (the "Ordinary Shares") on the London Stock Exchange from J&E Davy. The Ordinary Shares purchased will be cancelled.

London Stock Exchange

Number of Ordinary Shares purchased: 

55,000

Highest price paid per Ordinary Share:

155.00p

Lowest price paid per Ordinary Share:

154.60p

Volume weighted average price paid per Ordinary Share:

154.78p

 

The Ordinary Shares purchased form part of C&C's intention to buyback Ordinary Shares of a total value of up to ?15 million in the period up to 30 June 2024 ("Buyback Programme"). This Buyback Programme was announced on 21 February 2024 and formally commenced on 1 March 2024.

Following settlement of the above transactions and subsequent share cancellation C&C will have 392,396,412  Ordinary Shares in issue (excluding treasury shares).

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the "Market Abuse Regulation") (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made by J&E Davy as riskless principal on behalf of C&C on the London Stock Exchange as part of the Buyback Programme for subsequent repurchase by the Company is scheduled to this announcement.

Contact:

Mark Chilton

Company Secretary and General Counsel

company.secretary@candcgroup.ie

Issuer name:

C&C Group plc

 

LEI

635400LNUHA2LDXXV850

ISIN:

IE00B010DT83

Intermediary name:

J&E Davy

Intermediary code:

DAVYIE21

Time zone:

GMT

Currency:

GBp

Aggregated Information

Trading venue

Currency

Volume Weighted Average Price

Aggregated volume

London Stock Exchange

GBp

154.78p

55,000

London Stock Exchange

Number of Shares

Price per Share (GBp)

Trading Venue

Time of Transaction

MatchID

 

25000

155.00

LSE

11:32:11

00042118055TRLO0-1

 

30000

154.60

LSE

14:02:50

00042119108TRLO0-1

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGPUQUWUPCGRR
Date   Source Headline
21st Feb 20247:00 amRNSLaunch of EUR 15 Million Share Buyback Programme
15th Feb 20246:00 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSDirectorate Changes
2nd Feb 202410:00 amRNSTotal Voting Rights and Capital
15th Jan 20242:20 pmRNSDirector/PDMR Shareholding
4th Jan 202412:45 pmRNSTotal Voting Rights
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
12th Dec 20231:05 pmRNSHolding(s) in Company
6th Dec 20233:30 pmRNSDirectorate Change
5th Dec 20232:10 pmRNSBlock listing Interim Review
4th Dec 202311:15 amRNSTotal Voting Rights and Capital
16th Nov 20236:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20232:56 pmRNSHolding(s) in Company
2nd Nov 202312:44 pmRNSDirector/PDMR Shareholding
31st Oct 20233:00 pmRNSTotal Voting Rights
30th Oct 20233:45 pmRNSDirector/PDMR Shareholding
26th Oct 20237:00 amBUSHalf-year Report
16th Oct 20235:16 pmRNSDirector/PDMR Shareholding
6th Oct 202312:30 pmRNSHolding(s) in Company
27th Sep 20233:56 pmRNSHolding(s) in Company
19th Sep 20237:00 amBUSStatement re FY2024 H1 pre-close Trading Statement
15th Sep 20232:10 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSDirectorate Changes
18th Aug 20239:35 amRNSDirector Declaration
16th Aug 20234:15 pmRNSDirector/PDMR Shareholding
20th Jul 20239:00 amRNSDirector Declaration
17th Jul 20233:15 pmRNSDirector/PDMR Shareholding
13th Jul 20231:00 pmRNSResult of AGM
13th Jul 20237:00 amBUSAGM Statement
6th Jul 20234:00 pmRNSHolding(s) in Company
3rd Jul 20235:45 pmRNSHolding(s) in Company
26th Jun 202312:06 pmRNSHolding(s) in Company
16th Jun 20232:00 pmRNSDirector/PDMR Shareholding
14th Jun 20236:05 pmRNSDirector/PDMR Shareholding
14th Jun 20238:30 amRNSAnnual Report & Notice of AGM
13th Jun 20234:30 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSBlock listing Interim Review
30th May 20237:00 amRNSHolding(s) in Company
26th May 202312:15 pmRNSDirector/PDMR Shareholding
24th May 20231:45 pmRNSDirector/PDMR Shareholding
24th May 202312:00 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amBUSFinal Results
19th May 20237:00 amBUSStatement re Trading Update & Directorate Changes
16th May 20232:00 pmRNSDirector/PDMR Shareholding
4th May 20231:30 pmRNSHolding(s) in Company
17th Apr 20233:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amBUSPre-close Trading Statement
16th Mar 20233:15 pmRNSDirector/PDMR Shareholding
15th Mar 20232:00 pmRNSHolding(s) in Company
23rd Feb 202311:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.